{
  "questions": [
    {
      "stem": "Which of the following best characterizes the diagnostic criteria of delirium?",
      "options": [
        "A gradual onset of cognitive decline over months with no fluctuations and no attention disturbance",
        "A sudden disturbance in attention and awareness that fluctuates during the day, accompanied by at least one other cognitive disturbance",
        "Progressive memory loss without any changes in attention or awareness",
        "Steady cognitive decline accompanied by aphasia and apraxia in elderly individuals"
      ],
      "answer": "A sudden disturbance in attention and awareness that fluctuates during the day, accompanied by at least one other cognitive disturbance",
      "explanation": "Delirium is defined by a disturbance in attention and awareness that develops quickly (hours to days), fluctuates during the day, and includes an additional cognitive disturbance such as memory or language impairment.",
      "kn": "KN36",
      "kn_explanation": "The question focuses on clinical diagnostic criteria for delirium, relating to the understanding of classification systems and diagnosis in neurocognitive disorders.",
      "difficulty": "medium",
      "quality_comment": "The stem is clear, and distractors cover related but distinct disorders, promoting good differentiation of delirium from other conditions."
    },
    {
      "stem": "Which neuropathological feature is considered a hallmark of Alzheimer's disease?",
      "options": [
        "Lewy bodies consisting of alpha-synuclein deposits",
        "Multiple sclerosis plaques in the white matter",
        "Amyloid plaques and neurofibrillary tangles disrupting cell-to-cell communication",
        "Basal ganglia degeneration causing psychomotor retardation"
      ],
      "answer": "Amyloid plaques and neurofibrillary tangles disrupting cell-to-cell communication",
      "explanation": "Alzheimer's disease is characterized by extracellular amyloid plaques composed of beta-amyloid protein and intracellular neurofibrillary tangles made of abnormal tau protein, which interfere with neuronal communication.",
      "kn": "KN1",
      "kn_explanation": "This question targets knowledge of biological bases of neurocognitive disorders, specifically the neurobiological markers of Alzheimer's disease.",
      "difficulty": "medium",
      "quality_comment": "Options include other neurological features to mislead, but the correct response is clearly the signature pathological hallmark of Alzheimer's."
    },
    {
      "stem": "Which of the following is NOT a characteristic early symptom distinguishing the behavioral variant of frontotemporal neurocognitive disorder from Alzheimer's disease?",
      "options": [
        "Pronounced changes in social behavior and lack of empathy",
        "Memory impairment that interferes with social functioning",
        "Disinhibition and compulsive behaviors",
        "Prominent language deficits such as aphasia"
      ],
      "answer": "Memory impairment that interferes with social functioning",
      "explanation": "Early-stage frontotemporal neurocognitive disorder is marked by behavioral and personality changes, whereas memory impairment is a hallmark early symptom of Alzheimer's disease, not frontotemporal NCD.",
      "kn": "KN36",
      "kn_explanation": "This item assesses differential diagnosis based on clinical presentation between neurocognitive disorder subtypes, fitting into diagnosis and classification knowledge.",
      "difficulty": "hard",
      "quality_comment": "The question carefully distinguishes overlapping symptoms, requiring nuanced understanding of frontotemporal vs. Alzheimer's presentations."
    },
    {
      "stem": "A 72-year-old patient shows progressive memory loss and trouble with daily activities over several years. Genetic testing reveals an ApoE4 allele. What does this finding suggest about the patient’s neurocognitive disorder?",
      "options": [
        "The presence of the ApoE4 allele decreases the likelihood of Alzheimer’s disease",
        "The ApoE4 allele is a risk factor for Alzheimer’s disease and supports a probable diagnosis",
        "The ApoE4 allele is diagnostic for Lewy body dementia",
        "ApoE4 presence suggests the disorder is due to vascular causes"
      ],
      "answer": "The ApoE4 allele is a risk factor for Alzheimer’s disease and supports a probable diagnosis",
      "explanation": "The ApoE4 variant on chromosome 19 is a well-established genetic risk factor linked to increased likelihood of Alzheimer’s disease.",
      "kn": "KN4",
      "kn_explanation": "This question emphasizes behavioral genetics and the role of genetic risk factors in neurocognitive disorders.",
      "difficulty": "medium",
      "quality_comment": "Options are plausible and reflect common misunderstandings, making the question effective for testing genetic knowledge."
    },
    {
      "stem": "Which of the following medications primarily acts as a cholinesterase inhibitor used in treating Alzheimer’s disease?",
      "options": [
        "Memantine",
        "Donepezil",
        "Haloperidol",
        "Levodopa"
      ],
      "answer": "Donepezil",
      "explanation": "Donepezil is a cholinesterase inhibitor that delays breakdown of acetylcholine, helping reduce cognitive symptoms in Alzheimer’s disease, whereas memantine regulates glutamate, haloperidol is an antipsychotic, and levodopa is used in Parkinson’s disease.",
      "kn": "KN2",
      "kn_explanation": "The question tests knowledge of drug classification and mechanisms of action relevant to neurocognitive disorder pharmacotherapy.",
      "difficulty": "easy",
      "quality_comment": "The stem is straightforward and options are common drugs, ensuring clarity and good differentiation."
    },
    {
      "stem": "Which symptom is more typical of neurocognitive disorder with Lewy bodies than Alzheimer’s disease?",
      "options": [
        "Memory loss as the earliest symptom",
        "Fluctuating cognition and recurrent visual hallucinations",
        "Gradual decline in learning and memory",
        "Prominent early aphasia and apraxia"
      ],
      "answer": "Fluctuating cognition and recurrent visual hallucinations",
      "explanation": "NCD with Lewy bodies is characterized by fluctuating attention/alertness and recurrent visual hallucinations early in the course, which differ from the early predominant memory deficits in Alzheimer’s disease.",
      "kn": "KN36",
      "kn_explanation": "This focuses on clinical features aiding differential diagnosis between neurocognitive disorders.",
      "difficulty": "medium",
      "quality_comment": "Distractors reflect Alzheimer’s symptoms, enhancing discriminatory power of the question."
    },
    {
      "stem": "Which of the following best describes the prognosis and course of vascular neurocognitive disorder?",
      "options": [
        "A rapid, always steadily progressive decline similar to Alzheimer’s disease",
        "A stepwise decline or fluctuating symptom severity often related to cerebrovascular events",
        "A stable cognitive deficit with no further deterioration",
        "Primarily a reversible disorder with rapid full recovery"
      ],
      "answer": "A stepwise decline or fluctuating symptom severity often related to cerebrovascular events",
      "explanation": "Vascular NCD often presents with a stepwise decline or fluctuations in symptom intensity corresponding with strokes or cerebrovascular events.",
      "kn": "KN36",
      "kn_explanation": "This question addresses clinical course and prognosis relevant to diagnosis of neurocognitive disorders.",
      "difficulty": "medium",
      "quality_comment": "The question clearly differentiates vascular NCD from other neurocognitive disorders, useful for exam preparation."
    },
    {
      "stem": "A patient with Down syndrome in their 20s begins showing early signs of cognitive decline. Which neurocognitive disorder and mechanism is most consistent with this presentation?",
      "options": [
        "Lewy body dementia due to alpha-synuclein buildup",
        "Alzheimer’s disease associated with overproduction of amyloid precursor protein from trisomy 21",
        "Parkinson’s disease due to dopamine depletion",
        "Prion disease causing rapid cognitive deterioration"
      ],
      "answer": "Alzheimer’s disease associated with overproduction of amyloid precursor protein from trisomy 21",
      "explanation": "Individuals with Down syndrome have an extra copy of chromosome 21, leading to extra amyloid precursor protein production and greatly increased risk for early-onset Alzheimer’s disease.",
      "kn": "KN1",
      "kn_explanation": "Focuses on the genetic and biological bases of behavior underlying neurocognitive risk factors in a medical condition.",
      "difficulty": "medium",
      "quality_comment": "Question integrates genetics and clinical presentation effectively; distractors are plausible but biologically distinct."
    },
    {
      "stem": "Which feature distinguishes mild neurocognitive disorder from major neurocognitive disorder according to DSM-5-TR criteria?",
      "options": [
        "Mild NCD involves cognitive decline that interferes with independence in everyday activities",
        "Major NCD requires evidence of a medical condition explaining symptoms",
        "Mild NCD presents with modest decline that does not interfere with independence but may require compensatory strategies",
        "Delirium symptoms must be present to diagnose mild NCD"
      ],
      "answer": "Mild NCD presents with modest decline that does not interfere with independence but may require compensatory strategies",
      "explanation": "Mild NCD is characterized by modest cognitive decline that does not interfere with independence in daily activities but may require extra effort or strategies, whereas major NCD interferes with independence.",
      "kn": "KN36",
      "kn_explanation": "This deals with the diagnostic classification and differentiation between mild and major neurocognitive disorders.",
      "difficulty": "easy",
      "quality_comment": "Clear formulation contrasts mild vs. major NCD, with distractors that are partially true but misleading for diagnostic criteria."
    },
    {
      "stem": "In the assessment of Alzheimer’s disease, which statement about a definitive diagnosis is accurate?",
      "options": [
        "Definitive diagnosis is possible with clinical evaluation alone",
        "Brain biopsy is commonly used to confirm diagnosis during life",
        "Definitive diagnosis requires postmortem brain autopsy showing characteristic pathology",
        "Genetic testing alone can confirm Alzheimer’s disease diagnosis"
      ],
      "answer": "Definitive diagnosis requires postmortem brain autopsy showing characteristic pathology",
      "explanation": "A definitive diagnosis of Alzheimer’s disease is possible only with a postmortem brain autopsy revealing amyloid plaques and neurofibrillary tangles; brain biopsies are rarely done and clinical diagnosis is presumptive.",
      "kn": "KN33",
      "kn_explanation": "This question concerns assessment methods and limitations in diagnosis, emphasizing integration of non-psychological information.",
      "difficulty": "medium",
      "quality_comment": "The question clarifies a common misconception, with well-balanced distractors for clinical context."
    },
    {
      "stem": "Which intervention has recently been FDA approved to slow progression of early-stage Alzheimer’s disease by targeting amyloid plaques?",
      "options": [
        "Memantine",
        "Haloperidol",
        "Donepezil",
        "Donanemab"
      ],
      "answer": "Donanemab",
      "explanation": "Donanemab is a recently approved intravenous treatment that slows early-stage Alzheimer’s progression by reducing amyloid plaques in the brain.",
      "kn": "KN3",
      "kn_explanation": "Involves knowledge about recent pharmacological treatment advances for neurocognitive disorders, under pharmacotherapy guidelines.",
      "difficulty": "medium",
      "quality_comment": "Options are well-known drugs for neurocognitive or psychiatric disorders, increasing plausibility."
    },
    {
      "stem": "A patient with HIV shows forgetfulness, apathy, psychomotor slowing, and tremors. Which neurocognitive disorder subtype is most consistent with this presentation?",
      "options": [
        "Cortical neurocognitive disorder",
        "Subcortical neurocognitive disorder",
        "Cortico-subcortical neurocognitive disorder",
        "Behavioral variant frontotemporal neurocognitive disorder"
      ],
      "answer": "Subcortical neurocognitive disorder",
      "explanation": "NCD due to HIV infection affects subcortical brain areas leading to symptoms like psychomotor slowing, apathy, tremors, and cognitive slowing.",
      "kn": "KN36",
      "kn_explanation": "Focuses on understanding symptom patterns related to brain regions damaged, which is crucial for diagnosis.",
      "difficulty": "hard",
      "quality_comment": "Distractors include plausible brain region categories, requiring strong content knowledge for correct choice."
    },
    {
      "stem": "Which approach is recommended for treating agitation and psychotic symptoms in delirium in hospitalized older adults?",
      "options": [
        "Haloperidol or other antipsychotic medications",
        "Cholinesterase inhibitors like donepezil",
        "NMDA receptor antagonists like memantine",
        "Benzodiazepines as first-line agents"
      ],
      "answer": "Haloperidol or other antipsychotic medications",
      "explanation": "Treatment of agitation and psychotic symptoms in delirium often involves antipsychotics like haloperidol, while benzodiazepines are generally avoided unless delirium is due to withdrawal.",
      "kn": "KN3",
      "kn_explanation": "This question targets treatment guidelines and pharmacological management of delirium.",
      "difficulty": "easy",
      "quality_comment": "Clear question stem and relevant plausible options; distractors are pharmacologically related but distinct in use."
    },
    {
      "stem": "Which of the following factors is associated with increased risk for developing Alzheimer’s disease?",
      "options": [
        "High educational attainment",
        "Obesity and hearing loss",
        "Regular aerobic exercise",
        "Young age at onset"
      ],
      "answer": "Obesity and hearing loss",
      "explanation": "Obesity and hearing loss have been linked to increased risk of Alzheimer’s disease, whereas high education and exercise are protective factors.",
      "kn": "KN28",
      "kn_explanation": "Assesses knowledge of risk and protective factors impacting the course of neurocognitive disease across the lifespan.",
      "difficulty": "medium",
      "quality_comment": "Options balance protective and risk factors well, requiring applied knowledge."
    }
  ]
}